Crossmark

Systemic CD4 immunity: A powerful clinical biomarker for PD‐L1/PD‐1 immunotherapy

Crossref DOI link: https://doi.org/10.15252/emmm.202012706

Published Online: 2020-07-10

Published Print: 2020-09-07

Update policy: https://doi.org/10.1002/crossmark_policy

Authors

Zuazo, Miren

Arasanz, Hugo

Bocanegra, Ana

Chocarro, Luisa

Vera, Ruth https://orcid.org/0000-0003-1524-3147
Escors, David

Kagamu, Hiroshi https://orcid.org/0000-0003-4523-8517
Kochan, Grazyna
Funding

Funding for this research was provided by:

Instituto de Salud Carlos III (PI17/02119)

Fundación Científica Asociación Española Contra el Cáncer (PROYE16001ESCO)

Japan Agency for Medical Research and Development (19ae0101074h0001)

Departamento de Educación, Gobierno de Navarra (050‐2019)

Japan Society for the Promotion of Science (17H04184)
License Information

Version of Record valid from 2020-07-10
More Information

Publication History

Published: 2020-07-10